Abstract
A wastewater surveillance program targeting a university residence hall was implemented during the spring semester 2021 as a proactive measure to avoid an outbreak of COVID-19 on campus. Over a period of 7 weeks from early February through late March 2021, wastewater originating from the residence hall was collected as grab samples 3 times per week. During this time, there was no detection of SARS-CoV-2 by RT-qPCR in the residence hall wastewater stream. Aiming to obtain a sample more representative of the residence hall community, a decision was made to use passive samplers beginning in late March onwards. Adopting a Moore Swab approach, SARS-CoV-2 was detected in wastewater samples on just two days after passive samplers were activated. These samples were also positive for the B.1.1.7 (Alpha) Variant of Concern (VOC) by RT-qPCR. The positive result triggered a public health case finding response including a mobile testing unit deployed to the residence hall the following day with testing of nearly 200 students and staff, which identified two laboratory-confirmed cases of B.1.1.7 variant COVID-19. These individuals were re-located to a separate quarantine facility averting an outbreak on campus. Aggregating wastewater and clinical data, the campus wastewater surveillance program has yielded the first estimates of fecal shedding rates of the B.1.1.7 VOC of SARS-CoV-2 in individuals from a non-clinical setting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding in support of the Ontario Wastewater Surveillance Initiative was provided by the Ontario Ministry of Environment, Conservation and Parks. Additional support was provided by the Canada Foundation for Innovation - Exceptional Opportunities Fund (COVID-19 program) and by the Natural Sciences and Engineering Research Council of Canada (Alliance COVID-19 grant). Q. Geng received support through a MITACS Accelerate grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics consultation was sought from the University of Windsor's research ethics board and both the wastewater project and the information on the cases described were considered exempt from ethics review under the Canadian Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans TCPS 2 (2018) Articles 2.4 and 2.5. The Windsor-Essex County Health Unit reviewed the study and verified that no personal health information was involved in the analysis or summary. Thus this study is compliant with all applicable research ethics regulations. The University of Windsor is a registered IRB #00009591 under OHRP in the US.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# University of Windsor COVID-19 Case Response Team
Data Availability
Data available through online dashboard and Windsor-Essex County Health unit website.
https://www.wesparkhealth.com/covid-screening-platform#Dashboard
